Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the clinical efficacy of three doses of VR506
delivered via a new dry powder inhaler for the treatment of asthma.